For almost all of the last 40 years, Governments have aimed to make medicines less affordable, for everyone but them

In the final article in this week’s series on the transforming Pharmaceutical Benefits Scheme, we turn to a risk that increasingly shapes how the PBS is debated and understood. The challenge of recency bias. …